Functional genetic variants in the 3′-Untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity

Toxicological Sciences

Volumn 118, Issue 2, 2010, Pages 391-403

  Yu, Xinfeng ^a   Dhakal, Ishwori B ^a   Beggs, Marjorie ^a   Edavana, Vineetha Koroth ^a   Williams, Suzanne ^a   Zhang, Xuemei ^a   Mercer, Kelly ^a   Ning, Baitang ^b   Lang, Nicholas P ^a   Kadlubar, Fred F ^a   Kadlubar, Susan ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Genotype; Pharmacogenetics; Phenotype; SULT1A1

Indexed keywords

SULFOTRANSFERASE 1A1;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; ENZYME ACTIVITY; ETHNICITY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; MALE; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; ARYLSULFOTRANSFERASE; BLOOD PLATELETS; CYTOSOL; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78549246589     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq296     Document Type: Article

References (42)

1. Bartel, D.P., and Chen, C.Z. (2004). Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5, 396-400.
2. Campbell, N.R., Van Loon, J.A., and Weinshilboum, R.M. (1987). Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochem. Pharmacol. 36, 1435-1446.
3. Carlini, E.J., Raftogianis, R.B., Wood, T.C., Jin, F., Zheng, W., Rebbeck, T.R., and Weinshilboum, R.M. (2001). Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 11, 57-68.
4. Conrad, D.F., Andrews, T.D., Carter, N.P., Hurles, M.E., and Pritchard, J.K. (2006). A high-resolution survey of deletion polymorphism in the human genome. Nat. Genet. 38, 75-81.
5. Frame, L.T., Ozawa, S., Nowell, S.A., Chou, H.C., DeLongchamp, R.R., Doerge, D.R., Lang, N.P., and Kadlubar, F.F. (2000). A simple colorimetric assay for phenotyping the major human thermostable phenol sulfotransferase (SULT1A1) using platelet cytosols. Drug Metab. Dispos. 28, 1063-1068.
6. Ghazali, R.A., and Waring, R.H. (1999). The effects of flavonoids on human phenolsulphotransferases: potential in drug metabolism and chemoprevention. Life Sci. 65, 1625-1632.
7. Glatt, H. (1997). Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation. FASEB J. 11, 314-321.
8. Hebbring, S.J., Adjei, A.A., Baer, J.L., Jenkins, G.D., Zhang, J., Cunningham, J.M., Schaid, D.J., Weinshilboum, R.M., and Thibodeau, S.N. (2007). Human SULT1A1 gene: copy number differences and functional implications. Hum. Mol. Genet. 16, 463-470.
9. Hildebrandt, M., Adjei, A., Weinshilboum, R., Johnson, J.A., Berlin, D.S., Klein, T.E., and Altman, R.B. (2009). Very important pharmacogene summary: sulfotransferase 1A1. Pharmacogenet. Genomics. 19, 404-406.
10. Hinds, D.A., Kloek, A.P., Jen, M., Chen, X., and Frazer, K.A. (2006). Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat. Genet. 38, 82-85.
11. Iafrate, A.J., Feuk, L., Rivera, M.N., Listewnik, M.L., Donahoe, P.K., Qi, Y., Scherer, S.W., and Lee, C. (2004). Detection of large-scale variation in the human genome. Nat. Genet. 36, 949-951.
12. Jakoby, W.B., and Ziegler, D.M. (1990). The enzymes of detoxication. J. Biol. Chem. 265, 20715-20718.
13. Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M.L., Sjoqvist, F., and Ingelman-Sundberg, M. (1993). Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc. Natl. Acad. Sci. U.S.A. 90, 11825-11829.
14. Jones, A.L., Roberts, R.C., and Coughtrie, M.W. (1993). The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein. Biochem. J. 296(Pt 2), 287-290.
15. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408.
16. Marazziti, D., Palego, L., Mazzanti, C., Silvestri, S., and Cassano, G.B. (1995). Human platelet sulfotransferase shows seasonal rhythms. Chronobiol. Int. 12, 100-105.
17. Marazziti, D., Palego, L., Rossi, A., and Cassano, G.B. (1998). Genderrelated seasonality of human platelet phenolsulfotransferase activity. Neuropsychobiology 38, 1-5.
18. Mishra, P.J., Mishra, P.J., Banerjee, D., and Bertino, J.R. (2008). MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle 7, 853-858.
19. Mulder, G.J., Hinson, J.A., and Gillette, J.R. (1977). Generation of reactive metabolites of N-hydroxy-phenacetin by glucoronidation and sulfation. Biochem. Pharmacol. 26, 189-196.
20. Ning, B., Nowell, S., Sweeney, C., Ambrosone, C.B., Williams, S., Miao, X., Liang, G., Lin, D., Stone, A., Ratnasinghe, D.L., et al. (2005). Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity. Pharmacogenet. Genomics. 15, 465-473.
21. Nowell, S., Ambrosone, C.B., Ozawa, S., MacLeod, S.L., Mrackova, G., Williams, S., Plaxco, J., Kadlubar, F.F., and Lang, N.P. (2000). Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. Pharmacogenetics 10, 789-797.
22. Nowell, S., Ratnasinghe, D.L., Ambrosone, C.B., Williams, S., Teague-Ross, T., Trimble, L., Runnels, G., Carrol, A., Green, B., Stone, A., et al. (2004). Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol. Biomarkers Prev. 13, 270-276.
23. Nowell, S., Sweeney, C., Winters, M., Stone, A., Lang, N.P., Hutchins, L.F., Kadlubar, F.F., and Ambrosone, C.B. (2002). Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J. Natl. Cancer Inst. 94, 1635-1640.
24. Nowell, S.A., Ahn, J., Rae, J.M., Scheys, J.O., Trovato, A., Sweeney, C., MacLeod, S.L., Kadlubar, F.F., and Ambrosone, C.B. (2005). Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Res. Treat. 91, 249-258.
25. Ozawa, S., Shimizu, M., Katoh, T., Miyajima, A., Ohno, Y., Matsumoto, Y., Fukuoka, M., Tang, Y.M., Lang, N.P., and Kadlubar, F.F. (1999). Sulfating-activity and stability of cDNA-expressed allozymes of human phenol sulfotransferase, ST1A3*1 ((213)Arg) and ST1A3*2 ((213)His), both of which exist in Japanese as well as Caucasians. J. Biochem. 126, 271-277.
26. Ozawa, S., Tang, Y.M., Yamazoe, Y., Kato, R., Lang, N.P., and Kadlubar, F.F. (1998). Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem. Biol. Interact. 109, 237-248.
27. Pacifici, G.M. (2004). Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature. Int. J. Clin. Pharmacol. Ther. 42, 488-495.
28. Price, R.A., Cox, N.J., Spielman, R.S., Van Loon, J.A., Maidak, B.L., and Weinshilboum, R.M. (1988). Inheritance of human platelet thermolabile phenol sulfotransferase (TL PST) activity. Genet. Epidemiol. 5, 1-15.
29. Price, R.A., Spielman, R.S., Lucena, A.L., Van Loon, J.A., Maidak, B.L., and Weinshilboum, R.M. (1989). Genetic polymorphism for human platelet thermostable phenol sulfotransferase (TS PST) activity. Genetics 122, 905-914.
30. Raftogianis, R.B., Wood, T.C., Otterness, D.M., Van Loon, J.A., and Weinshilboum, R.M. (1997). Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem. Biophys. Res. Commun. 239, 298-304.
31. Raftogianis, R.B., Wood, T.C., and Weinshilboum, R.M. (1999). Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem. Pharmacol. 58, 605-616.
32. Rehmsmeier, M., Steffen, P., Hochsmann, M., and Giegerich, R. (2004). Fast and effective prediction of microRNA/target duplexes. RNA 10, 1507-1517.
33. Reveley, A.M., Bonham Carter, S.M., Reveley, M.A., and Sandler, M. (1982). A genetic study of platelet phenolsulphotransferase activity in normal and schizophrenic twins. J. Psychiatr. Res. 17, 303-307.
34. Rusinov, V., Baev, V., Minkov, I.N., and Tabler, M. (2005). MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res. 33, W696-W700.
35. Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., Maner, S., Massa, H., Walker, M., Chi, M., et al. (2004). Large-scale copy number polymorphism in the human genome. Science 305, 525-528.
36. Stephens, M., and Donnelly, P. (2003). A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 73, 1162-1169.
37. Stephens, M., Smith, N.J., and Donnelly, P. (2001). A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978-989.
38. Sundaram, R.S., Szumlanski, C., Otterness, D., van Loon, J.A., and Weinshilboum, R.M. (1989). Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form. Drug Metab. Dispos. 17, 255-264.
39. Van Loon, J., and Weinshilboum, R.M. (1984). Human platelet phenol sulfotransferase: familial variation in thermal stability of the TS form. Biochem. Genet. 22, 997-1014.
40. Vietri, M., Pietrabissa, A., Mosca, F., Spisni, R., and Pacifici, G.M. (2003). Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues. Xenobiotica 33, 357-363.
41. Waring, R.H., Ayers, S., Gescher, A.J., Glatt, H.R., Meinl, W., Jarratt, P., Kirk, C.J., Pettitt, T., Rea, D., and Harris, R.M. (2008). Phytoestrogens and xenoestrogens: the contribution of diet and environment to endocrine disruption. J. Steroid Biochem. Mol. Biol. 108, 213-220.
42. Zhao, J.H. (2004). 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 20, 1325-1326.